SHASHANK B RADADIYA
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology KANSAS CITY, KS NPI 1306887161
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology KS ABBVIE INC. All categories
General Payments — all program years on this page
$83,313.29
- Category: General Payments
- Program years: PY2018–2024
- Record count: 780
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $8,437.04 across 102 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,375.00 | 4 |
| Food and Beverage | $2,008.44 | 96 |
| Travel and Lodging | $53.60 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $7,028.15 | 36 |
| Amgen Inc. | $889.54 | 44 |
| Acerta Pharma LLC | $74.51 | 2 |
| Alexion Pharmaceuticals, Inc. | $68.88 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $67.92 | 4 |
| E.R. Squibb & Sons, L.L.C. | $53.02 | 3 |
| UCB, Inc. | $44.32 | 2 |
| Lilly USA, LLC | $38.65 | 2 |
| Mallinckrodt Hospital Products Inc. | $36.23 | 1 |
| Organon LLC | $35.72 | 2 |
| Novo Nordisk AS | $26.49 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.38 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.74 | 1 |
| GENZYME CORPORATION | $15.40 | 1 |
| Janssen Biotech, Inc. | $14.09 | 1 |
By program year
Records — PY2024 (102)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.